TRMT12

Chr 8

tRNA wybutosine-synthesizing protein 2

Also known as: TRM12, TRMT12

The protein catalyzes transfer of amino acid groups from S-adenosyl-L-methionine during wybutosine biosynthesis, producing a hypermodified guanosine that stabilizes codon-anticodon interactions in phenylalanine tRNA during ribosomal protein synthesis. Mutations cause intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, inherited in an autosomal recessive pattern. The gene shows significant constraint against loss-of-function variants (LOEUF 0.53), indicating intolerance to complete protein loss.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.53
Clinical SummaryTRMT12
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.23) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.53LOEUF
pLI 0.326
Z-score 2.96
OE 0.23 (0.110.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.15Z-score
OE missense 0.97 (0.871.08)
230 obs / 236.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.23 (0.110.53)
00.351.4
Missense OE0.97 (0.871.08)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 4 / 17.2Missense obs/exp: 230 / 236.6Syn Z: -0.11

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TRMT12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗